生物科技公司荣昌生物（09995）今日盘中大跌6.56%，引发市场关注。虽然没有直接相关的重大新闻公告，但前一交易日的数据可能为这一跌幅提供了一些线索。
根据11月11日的披露数据，荣昌生物的港股通持股比例下降了0.30%，最新持股比例为51.41%。这一变动表明北向资金可能正在减持该股票。此外，当日的资金流向数据显示，主力资金净流出4743.98万元，占总成交额的11.97%，而散户资金则净流入4816.72万元。这种资金流向模式可能预示着机构投资者正在减持，而散户投资者则在买入。
尽管公司最新发布的2025年第三季度财报显示营收同比增长33.13%，达到6.22亿元，净亏损同比收窄65.24%至1.01亿元，但投资者似乎对公司短期内仍未能实现盈利表示担忧。分析人士指出，生物科技股往往具有高风险高收益的特征，投资者对公司的研发进展和商业化前景保持谨慎态度可能是导致股价下跌的另一个因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.